Contact
Please use this form to send email to PR contact of this press release:
Vidac Pharma Announces Publication of New Peer-Reviewed Study Highlighting Breakthrough Anti-Cancer Mechanism of VDA1275
TO:
Max Herzberg / Sandra Gamzon
Vidac pharma Holding Plc
+972 54-425-7381